Bibliography
Found 87 results
Filters: Author is Elyse J. Singer [Clear All Filters]
Blood and brain HIV strain variation. In: The Spectrum of NeuroAIDS Disorders: Pathophysiology, Diagnosis, and Treatment. The Spectrum of NeuroAIDS Disorders: Pathophysiology, Diagnosis, and Treatment. ASM Press; 2008.
Neuropathology of HIV-1 disease. In: Global Virology II - HIV and NeuroAIDS. 1st ed. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 143-208.
. The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART). In: Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 375-403.
. Assessment of the NEUROPSI in Detecting Neurocognitive Deficits in HIV+ Spanish Speakers. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Brain gene array reveals CNS adaptation and two different kinds of HIV-associated neurocognitive disorder. In: American Association of Neuropathologists 85 Annual Meeting. American Association of Neuropathologists 85 Annual Meeting. San Antonio, Texas; 2009. p. abstract #95.
A candidate gene study of HIV-dementia in the National NeuroAIDS Tissue Consortium. In: 2nd Annual AIDS Research Symposium at UCLA. 2nd Annual AIDS Research Symposium at UCLA. ; 2009.
. Comparing the accuracy of neuropsychological testing methods in determining neurocognitive impairment in HIV-infected Spanish speaking adults. In: UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. Los Angeles, CA; 2010.
. COMT val168met polymorphism confers risk for working memory impairment in HIV. In: Third Meeting on HIV Infection and the Central Nervous System. Third Meeting on HIV Infection and the Central Nervous System. Stresa, Italy; 2009.
. Cross-section effects of APOE E4 by Discrete Neurocognitive Domain. In: 40th Annual Conference of the International Neuropsychological Society. 40th Annual Conference of the International Neuropsychological Society. ; 2012.
. Dopamine-related genes affect cognitive functioning and risk for HIV-associated neurocognitive disorders. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Education stratification based on education versus reading ability: a comparison of diagnostic accuracy of neurocognitive impairment in HIV. In: Western Student Medical Research Forum (WSMRF). Western Student Medical Research Forum (WSMRF). Carmel, CA; 2006.
. Ethnicity and Risk for HIV-Associated Neurocognitive Disorders. In: HIV Research: The Next Generation Conference. HIV Research: The Next Generation Conference. Los Angeles, CA; 2007.
. Genome-Wide Association Study of HIV-Related Neurocognitive Decline and Dementia. In: 19th Conference on Retroviruses and Opportunistic Infections. 19th Conference on Retroviruses and Opportunistic Infections. ; 2012.
. Gray matter atrophy among older adults with HIV: The effects of age and disease status. In: 9th annual meeting of the American Academy of Clinical Neuropsychology. 9th annual meeting of the American Academy of Clinical Neuropsychology. Washington, DC; 2010.
. HIV-1 Infection in the CNS in Post-cART Era: Impact of Infection on Serotonergic Status in Different Regions of Post Mortem Brain. In: 12th International Symposium on NeuroVirology. 12th International Symposium on NeuroVirology. ; 2013.
. HIV-Infection: CNS Dopamine & Cognition. In: 6th Internation Symposium on Neurovirology. 6th Internation Symposium on Neurovirology. Sardinia, Italy; 2004.
. The Interplay between APOE EF, Disease Severity, and Cognition. In: 92nd Annual Conference of the Western Psychological Association. 92nd Annual Conference of the Western Psychological Association. ; 2012.
. Longitudinal effects of APOE e4 on HIV-Associated Neurocognitive Dysfunction. In: Annual Meeting of the International Neuropsychological Society. Annual Meeting of the International Neuropsychological Society. ; 2012.
. Long-term outcome of everyday functioning and neurocognitive ability following CNS opportunistic infection in AIDS. In: 132nd Annual Meeting of the American Neurological Assocation. 132nd Annual Meeting of the American Neurological Assocation. Washington, D.C.; 2007.
Monocyte Activation Markers in Cerebrospinal Fluid Are Associated with Impaired Neurocognitive Testing in Advanced HIV Infection. In: AAN Meeting. AAN Meeting. New Orleans, Louisiana; 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22569268
. The National NeuroAIDS Tissue Consortium: A new resource to support studies on neuropathogenesis for HIV. In: Journal of NeuroVirology. Vol. 6. Journal of NeuroVirology. ; 2000. p. 244.
. National NeuroAIDS Tissue Consortium [NNTC]. In: Journal of NeuroVirology. Vol. 9. S3th ed. Journal of NeuroVirology. ; 2003. p. 113.
. National NeuroAIDS Tissue Network (NNTC). In: International AIDS Conference. International AIDS Conference. Bangkok, Thailand; 2004.
. Neurocognitive outcomes in HIV+ abstinent cocaine versus methamphetamine users. In: 2nd Annual AIDS Research Symposium at UCLA. 2nd Annual AIDS Research Symposium at UCLA. ; 2009.
. Neuropsychological effects of HIV and Hepatitis C co-infection. In: 34th Annual Meeting of the International Neuropsychological Society. 34th Annual Meeting of the International Neuropsychological Society. Boston, MA; 2006.
.